2016 Digestive Disease Week

Caroline Helwick / June 25, 2016 / 2016 Digestive Disease Week

Expert Point of View: Samir Gupta, MD

Samir Gupta, MD, Associate Professor of Medicine at the University of California San Diego, who has led trials of colorectal cancer screening, commented on this study for The ASCO Post. Although the...

Colorectal Cancer

Caroline Helwick / June 25, 2016 / 2016 Digestive Disease Week

Young-Onset Colorectal Cancer Diagnoses Rising

Colorectal cancer is being increasingly diagnosed in persons younger than age 50, the age at which colorectal cancer screening is usually initiated. According to Elie Sutton, MD, of Mount Sinai West...

Aug

Today In Oncology

FDA Approves Lenvatinib for Unresectable Hepatocellular Carcinoma

Issues in Doctor-Patient Discussions on Potential Harms of Lung Cancer Screening

VB4-845 Granted Fast Track Designation by FDA for Treatment of Non–Muscle Invasive Bladder Cancer

Basal Cell Carcinoma and Risk for Development of Other Cancers

Broad-Based Genomic Sequencing in Advanced NSCLC in the Community Oncology Setting

;

2016 Digestive Disease Week

Expert Point of View: Samir Gupta, MD

Young-Onset Colorectal Cancer Diagnoses Rising

FDA Approves Lenvatinib for Unresectable Hepatocellular Carcinoma

Issues in Doctor-Patient Discussions on Potential Harms of Lung Cancer Screening

VB4-845 Granted Fast Track Designation by FDA for Treatment of Non–Muscle Invasive Bladder Cancer

Basal Cell Carcinoma and Risk for Development of Other Cancers

Broad-Based Genomic Sequencing in Advanced NSCLC in the Community Oncology Setting

Enzalutamide Prolongs Metastasis-Free Survival in Patients With Nonmetastatic, Castration-Resistant Prostate Cancer

New Frontiers Being Explored in Multiple Myeloma

No Benefit of Adding Abiraterone to Enzalutamide in Metastatic Castration-Resistant Prostate Cancer With Increasing PSA

Apatinib and Oral Etoposide in Platinum-Resistant/Refractory Ovarian Cancer

Long-Term Pooled Safety Data for Palbociclib Combined With Endocrine Therapy in HR-Positive, HER2-Negative Breast Cancer

Gilberto Lopes, MD, MBA, on NSCLC: Results From the KEYNOTE-042 Trial

Gabriel N. Hortobagyi, MD, on Breast Cancer Staging: New and Important Changes

Jonathan W. Friedberg, MD, on Follicular Lymphoma: Novel Combination Therapies

Melinda Telli, MD, on Triple-Negative Breast Cancer: New Clinical Approaches

Sherry Shen, MD, on Breast Cancer and Obesity: Results of the SWOG S0927 Study